Ana Paula Silva de Lemos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Paula Silva de Lemos has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Henrique Camargo
Centro de Bacteriologia, Instituto Adolfo Lutz, São Paulo, Brazil
4 shared publications - Samanta Cristine Grassi Almeida
Center of Bacteriology, Adolfo Lutz Institute, Sao Paulo, Brazil
4 shared publications Claudio Tavares Sacchi
Strategic Laboratory, Institute Adolfo Lutz (IAL) , São Paulo
3 shared publications- Karoline Rodrigues Campos
Laboratório Estratégico, Instituto Adolfo Lutz , São Paulo
3 shared publications - Maria Cecilia Outeiro Gorla
Centro de Bacteriologia, Instituto Adolfo Lutz, São Paulo, Brazil
3 shared publications Carlos Henrique Camargo
Centro de Bacteriologia, Instituto Adolfo Lutz (IAL)
2 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357903
Nasopharyngeal carriage of Streptococcus pneumoniae in children aged two to five years old in the conjugate vaccine era: A cross-sectional study in Salvador, Brazil
Background: Monitoring the prevalence and serotype distribution of Streptococcus pneumoniae nasopharyngeal carriage is essential for understanding transmission dynamics and assessing the impact of pneumococcal conjugate vaccines (PCVs). In Brazil, PCV10-GSK is routinely administered at 2 and 4 months of age with a booster at 12 months. This study aimed to determine the nasopharyngeal carriage rate, serotype distribution, antimicrobial susceptibility, and factors associated with carriage among healthy children aged 2–5 years vaccinated with PCV10-GSK under the Brazilian routine immunization program. Methods: A cross-sectional study was conducted from August to November 2023 among children aged two to five years from 10 randomly selected schools in Salvador, Brazil. Within each school, all eligible children whose parents or legal guardians provided written informed consent were enrolled. Nasopharyngeal swabs were collected, and demographic, vaccination, and risk factor data were recorded. S. pneumoniae isolates were serotyped using multiplex polymerase chain reaction and/or the Quellung reaction. Antimicrobial susceptibility was evaluated using disk diffusion and gradient strip minimum inhibitory concentration methods. Risk factors for carriage were assessed using univariate and multivariable logistic regression analysis. Results: Among the 400 children enrolled, the overall S. pneumoniae carriage rate was 39.5%. White race was independently associated with lower odds of carriage compared with mixed race, whereas none of the evaluated factors was significantly associated with carriage of non-PCV20 serotypes among colonized children. The most frequent serotypes were 6C (17.9%), 19A (13.0%), 11A (9.3%), 15B (8.6%), 23A (8.6%), and 15A (7.4%). Estimated vaccine serotype carriage was 3.2% for PCV10-GSK, 17.3% for PCV13/PCV15/PCV10-SII, and 39.5% for PCV20. Penicillin non-susceptibility was observed in 21.8% of isolates, with the highest rates among serotypes 19A (71.4%), 23A (35.7%), and 6C (20.7%). Conclusions: A high pneumococcal carriage rate, predominantly involving non-PCV10-GSK serotypes, was observed among children vaccinated under the Brazilian PCV10-GSK program. The limited serotype coverage of PCV10-GSK, together with antimicrobial resistance among circulating serotypes, underscores the need for ongoing surveillance to guide vaccine policy and antimicrobial stewardship in Brazil.
- 9 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357903
Open AccessNasopharyngeal carriage of Streptococcus pneumoniae in children aged two to five years old in the conjugate vaccine era: A cross-sectional study in Salvador, Brazil
Background: Monitoring the prevalence and serotype distribution of Streptococcus pneumoniae nasopharyngeal carriage is essential for understanding transmission dynamics and assessing the impact of pneumococcal conjugate vaccines (PCVs). In Brazil, PCV10-GSK is routinely administered at 2 and 4 months of age with a booster at 12 months. This study aimed to determine the nasopharyngeal carriage rate, serotype distribution, antimicrobial susceptibility, and factors associated with carriage among healthy children aged 2–5 years vaccinated with PCV10-GSK under the Brazilian routine immunization program. Methods: A cross-sectional study was conducted from August to November 2023 among children aged two to five years from 10 randomly selected schools in Salvador, Brazil. Within each school, all eligible children whose parents or legal guardians provided written informed consent were enrolled. Nasopharyngeal swabs were collected, and demographic, vaccination, and risk factor data were recorded. S. pneumoniae isolates were serotyped using multiplex polymerase chain reaction and/or the Quellung reaction. Antimicrobial susceptibility was evaluated using disk diffusion and gradient strip minimum inhibitory concentration methods. Risk factors for carriage were assessed using univariate and multivariable logistic regression analysis. Results: Among the 400 children enrolled, the overall S. pneumoniae carriage rate was 39.5%. White race was independently associated with lower odds of carriage compared with mixed race, whereas none of the evaluated factors was significantly associated with carriage of non-PCV20 serotypes among colonized children. The most frequent serotypes were 6C (17.9%), 19A (13.0%), 11A (9.3%), 15B (8.6%), 23A (8.6%), and 15A (7.4%). Estimated vaccine serotype carriage was 3.2% for PCV10-GSK, 17.3% for PCV13/PCV15/PCV10-SII, and 39.5% for PCV20. Penicillin non-susceptibility was observed in 21.8% of isolates, with the highest rates among serotypes 19A (71.4%), 23A (35.7%), and 6C (20.7%). Conclusions: A high pneumococcal carriage rate, predominantly involving non-PCV10-GSK serotypes, was observed among children vaccinated under the Brazilian PCV10-GSK program. The limited serotype coverage of PCV10-GSK, together with antimicrobial resistance among circulating serotypes, underscores the need for ongoing surveillance to guide vaccine policy and antimicrobial stewardship in Brazil.
- Open Access
- 1 August 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (8)
Ongoing Outbreak of Neisseria meningitidis Serogroup B in Pará State, Brazilian Amazon Region, Following the COVID-19 Pandemic
Background: Invasive meningococcal disease (IMD) remains a major cause of mortality worldwide, yet its dynamics in the Brazilian Amazon are poorly understood. Following the COVID-19 pandemic, serogroup B IMD resurged in Brazil, raising concerns about changing transmission patterns in regions with limited healthcare access. Methods: We conducted an epidemiological and genomic investigation of an ongoing IMD outbreak in Pará State, Brazilian Amazon, between 2023 and 2025. Clinical, demographic, and outcome data were integrated with whole-genome sequencing of 69 isolates. Multivariate logistic regression identified independent predictors of mortality, and phylogenomic analyses characterized transmission dynamics and clonal expansion. Results: A total of 343 IMD cases were identified, of which 321 (93.6%) were caused by serogroup B, resulting 34 deaths (case-fatality rate, 10.6%). Incidence increased up to 5-fold compared with national rates and disproportionately affected young children and adults. Mortality was independently associated with meningococcemia (adjusted odds ratio, 84.52; 95% confidence interval, 5.70–1253.65; P = .001); however, this finding should be interpreted with caution due to the small number of meningococcemia cases. Genomic analysis identified a predominant ST-7983/cc60 lineage, accounting for 64 of 69 sequenced isolates (92.7%). This lineage displayed limited genetic diversity (median, 7 single nucleotide polymorphisms), consistent with sustained regional transmission across multiple municipalities. Conclusions: A highly clonal serogroup B meningococcal outbreak emerged in the Brazilian Amazon following the COVID-19 pandemic, with substantial mortality and rapid geographic spread. These findings highlight the importance of strengthened genomic surveillance and support targeted vaccination strategies to improve outbreak preparedness in underserved regions.
- 1 August 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (8)
Open AccessOngoing Outbreak of Neisseria meningitidis Serogroup B in Pará State, Brazilian Amazon Region, Following the COVID-19 Pandemic
Background: Invasive meningococcal disease (IMD) remains a major cause of mortality worldwide, yet its dynamics in the Brazilian Amazon are poorly understood. Following the COVID-19 pandemic, serogroup B IMD resurged in Brazil, raising concerns about changing transmission patterns in regions with limited healthcare access. Methods: We conducted an epidemiological and genomic investigation of an ongoing IMD outbreak in Pará State, Brazilian Amazon, between 2023 and 2025. Clinical, demographic, and outcome data were integrated with whole-genome sequencing of 69 isolates. Multivariate logistic regression identified independent predictors of mortality, and phylogenomic analyses characterized transmission dynamics and clonal expansion. Results: A total of 343 IMD cases were identified, of which 321 (93.6%) were caused by serogroup B, resulting 34 deaths (case-fatality rate, 10.6%). Incidence increased up to 5-fold compared with national rates and disproportionately affected young children and adults. Mortality was independently associated with meningococcemia (adjusted odds ratio, 84.52; 95% confidence interval, 5.70–1253.65; P = .001); however, this finding should be interpreted with caution due to the small number of meningococcemia cases. Genomic analysis identified a predominant ST-7983/cc60 lineage, accounting for 64 of 69 sequenced isolates (92.7%). This lineage displayed limited genetic diversity (median, 7 single nucleotide polymorphisms), consistent with sustained regional transmission across multiple municipalities. Conclusions: A highly clonal serogroup B meningococcal outbreak emerged in the Brazilian Amazon following the COVID-19 pandemic, with substantial mortality and rapid geographic spread. These findings highlight the importance of strengthened genomic surveillance and support targeted vaccination strategies to improve outbreak preparedness in underserved regions.
- 23 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (6) , 1120-1129
Stepwise Evolution of Triple Antimicrobial Resistance in Neisseria meningitidis
Background: Invasive meningococcal disease is a rapidly progressive infection with high mortality, for which effective antimicrobial therapy and chemoprophylaxis are essential. During national surveillance in El Salvador, invasive Neisseria meningitidis serogroup Y isolates with resistance to first-line agents were identified, prompting further investigation. Methods: Ten invasive N. meningitidis serogroup Y isolates, selected for dual resistance to penicillin and ciprofloxacin and collected between 2020 and 2025 by the National Public Health Laboratory of El Salvador, were analyzed at the Adolfo Lutz Institute, São Paulo, Brazil. Antimicrobial susceptibility testing was performed by minimum inhibitory concentration determination, and resistance mechanisms were characterized by whole-genome sequencing. Results: All isolates were resistant to penicillin and ciprofloxacin. Genomic analysis showed that penicillin resistance was mediated by acquisition of the β-lactamase gene blaROB-1, while ciprofloxacin resistance was associated with a threonine-to-isoleucine substitution at position 91 of DNA gyrase (gyrA T91I). Two isolates additionally carried the tetB gene, defining a triple-resistance phenotype. These isolates exhibited markedly elevated tetracycline minimum inhibitory concentrations (6 μg/mL), approximately 40-fold higher than those observed in tetracycline-susceptible isolates. Increased MICs were also observed for minocycline and doxycycline, whereas susceptibility to newer tetracycline derivatives, including tigecycline and eravacycline, was preserved. All isolates belonged to sequence type 3587 within clonal complex 23. Conclusions: We report the first identification of N. meningitidis with concurrent resistance to penicillin, ciprofloxacin, and tetracycline, mediated by blaROB-1, gyrA T91I, and tetB, representing a critical escalation in meningococcal antimicrobial resistance.
- 23 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (6) , 1120-1129
Stepwise Evolution of Triple Antimicrobial Resistance in Neisseria meningitidis
Background: Invasive meningococcal disease is a rapidly progressive infection with high mortality, for which effective antimicrobial therapy and chemoprophylaxis are essential. During national surveillance in El Salvador, invasive Neisseria meningitidis serogroup Y isolates with resistance to first-line agents were identified, prompting further investigation. Methods: Ten invasive N. meningitidis serogroup Y isolates, selected for dual resistance to penicillin and ciprofloxacin and collected between 2020 and 2025 by the National Public Health Laboratory of El Salvador, were analyzed at the Adolfo Lutz Institute, São Paulo, Brazil. Antimicrobial susceptibility testing was performed by minimum inhibitory concentration determination, and resistance mechanisms were characterized by whole-genome sequencing. Results: All isolates were resistant to penicillin and ciprofloxacin. Genomic analysis showed that penicillin resistance was mediated by acquisition of the β-lactamase gene blaROB-1, while ciprofloxacin resistance was associated with a threonine-to-isoleucine substitution at position 91 of DNA gyrase (gyrA T91I). Two isolates additionally carried the tetB gene, defining a triple-resistance phenotype. These isolates exhibited markedly elevated tetracycline minimum inhibitory concentrations (6 μg/mL), approximately 40-fold higher than those observed in tetracycline-susceptible isolates. Increased MICs were also observed for minocycline and doxycycline, whereas susceptibility to newer tetracycline derivatives, including tigecycline and eravacycline, was preserved. All isolates belonged to sequence type 3587 within clonal complex 23. Conclusions: We report the first identification of N. meningitidis with concurrent resistance to penicillin, ciprofloxacin, and tetracycline, mediated by blaROB-1, gyrA T91I, and tetB, representing a critical escalation in meningococcal antimicrobial resistance.
- Open Access
- 19 January 2026
- Published by Frontiers Media SA in Frontiers in Bacteriology
- Vol. 4, 1718207
Genomic characterization of Corynebacterium diphtheriae isolates from human origin in Brazil, 1974-2024
Introduction: Diphtheria is a potentially fatal disease that still causes deaths mainly in unvaccinated children. Over the last decades, the incidence of this disease has reduced drastically in face to the increase in vaccination coverage. Diphtheria is mainly caused by toxigenic Corynebacterium diphtheriae , however, in more recent years, invasive infections due to nontoxigenic Corynebacterium diphtheriae have emerged. Given this epidemiological threat, the continued surveillance remains essential to guide prevention and control measures. Methodology: Using whole genome sequencing, we characterized 299 Corynebacterium diphtheriae isolates, assessing their clinical origin, age distribution of patients, tox gene carriage, antimicrobial resistance markers, and phylogenetic relationships. Results: The tox gene was identified in 255 isolates (85.3%). Antimicrobial resistance genes aph(3’’)-Ib , aph(3’)-Ia , aph(6)Id , cmx , tet(33) , tet(O) , tet(W) , and tet(Z) were detected in low (sul1 was found in 72 (24.1%) isolates. Phylogenetic analyses identified 11 main clades comprising 286 isolates, represented by 46 different sequence types (ST); the remaining 13 isolates were distributed in the other 12 ST. Twenty-one novel ST were described, comprising 51 isolates. Discussion: Our study represents the largest genomic survey of Corynebacterium diphtheriae in Latin America. These results enhance global understanding of diphtheria and reinforce the need for vigilance against reemergence in areas with suboptimal vaccination coverage.
- 19 January 2026
- Published by Frontiers Media SA in Frontiers in Bacteriology
- Vol. 4, 1718207
Open AccessGenomic characterization of Corynebacterium diphtheriae isolates from human origin in Brazil, 1974-2024
Introduction: Diphtheria is a potentially fatal disease that still causes deaths mainly in unvaccinated children. Over the last decades, the incidence of this disease has reduced drastically in face to the increase in vaccination coverage. Diphtheria is mainly caused by toxigenic Corynebacterium diphtheriae , however, in more recent years, invasive infections due to nontoxigenic Corynebacterium diphtheriae have emerged. Given this epidemiological threat, the continued surveillance remains essential to guide prevention and control measures. Methodology: Using whole genome sequencing, we characterized 299 Corynebacterium diphtheriae isolates, assessing their clinical origin, age distribution of patients, tox gene carriage, antimicrobial resistance markers, and phylogenetic relationships. Results: The tox gene was identified in 255 isolates (85.3%). Antimicrobial resistance genes aph(3’’)-Ib , aph(3’)-Ia , aph(6)Id , cmx , tet(33) , tet(O) , tet(W) , and tet(Z) were detected in low (sul1 was found in 72 (24.1%) isolates. Phylogenetic analyses identified 11 main clades comprising 286 isolates, represented by 46 different sequence types (ST); the remaining 13 isolates were distributed in the other 12 ST. Twenty-one novel ST were described, comprising 51 isolates. Discussion: Our study represents the largest genomic survey of Corynebacterium diphtheriae in Latin America. These results enhance global understanding of diphtheria and reinforce the need for vigilance against reemergence in areas with suboptimal vaccination coverage.
- Open Access
Oropouche Virus Outbreak in Southeast, Brazil: Expanding Beyond the Amazonian Endemic Region
The Oropouche virus (OROV), historically endemic to the Amazon, has spread to nearly all Brazilian states in 2024, with Espírito Santo emerging as a significant transmission hotspot in the Atlantic Forest biome. We characterized the epidemiological factors driving OROV spread in non-endemic Southeast Brazil, analyzing environmental and agricultural conditions contributing to viral transmission. Samples from 29,000 suspected arbovirus-infected patients were tested by RT-qPCR for Dengue, Chikungunya, Zika, Mayaro, and Oropouche virus. Between March and June 2024, OROV cases in the state reached 339, demonstrating successful local transmission. Spatial analysis revealed that most cases clustered in municipalities with tropical climates and intensive cacao, robusta coffee, coconut, and pepper cultivation. Phylogenetic analysis identified the Espírito Santo OROV strains as part of the 2022-2024 Amazonian lineage. The rapid spread of OROV outside the Amazon highlights its adaptive potential and public health threat, emphasizing the need for enhanced surveillance and targeted control measures.
Open AccessOropouche Virus Outbreak in Southeast, Brazil: Expanding Beyond the Amazonian Endemic Region
The Oropouche virus (OROV), historically endemic to the Amazon, has spread to nearly all Brazilian states in 2024, with Espírito Santo emerging as a significant transmission hotspot in the Atlantic Forest biome. We characterized the epidemiological factors driving OROV spread in non-endemic Southeast Brazil, analyzing environmental and agricultural conditions contributing to viral transmission. Samples from 29,000 suspected arbovirus-infected patients were tested by RT-qPCR for Dengue, Chikungunya, Zika, Mayaro, and Oropouche virus. Between March and June 2024, OROV cases in the state reached 339, demonstrating successful local transmission. Spatial analysis revealed that most cases clustered in municipalities with tropical climates and intensive cacao, robusta coffee, coconut, and pepper cultivation. Phylogenetic analysis identified the Espírito Santo OROV strains as part of the 2022-2024 Amazonian lineage. The rapid spread of OROV outside the Amazon highlights its adaptive potential and public health threat, emphasizing the need for enhanced surveillance and targeted control measures.
- 15 May 2024
- Published by Springer Nature in International Microbiology
- Vol. 28 (1) , 157-163
Trends in serotype distribution and antimicrobial susceptibility pattern of invasive Haemophilus influenzae isolates from Brazil, 2009–2021
Introduction Invasive Haemophilus influenzae (Hi) disease poses a significant global health challenge. With the relaxation of COVID-19 pandemic measures and declining H. influenzae serotype b (Hib) vaccination coverage, there is concern about a potential increase in Hi cases worldwide. Methodology This study analyzed 1437 invasive Hi isolates in Brazil over 13 years, determining capsular serotypes, antimicrobial susceptibility, and genetic relatedness through multilocus sequence typing. Results The primary source of isolation for these invasive H. influenzae isolates was blood (54.4%), followed by cerebrospinal fluid (37.1%) and lung specimens (8.5%), respectively. Consequently, bacteremia (47%) was the most common clinical presentation, followed by meningitis (39.6%) and pneumonia (13.4%). Non-encapsulated Hi (NTHi) predominated among the isolates (51.4%), along with serotype a (22%) and serotype b (21.5%) among the encapsulated isolates. The majority of the encapsulated isolates were isolated from children under 14 years of age (76.7%), while NTHi isolates were identified in patients older than 15 years, particularly those ≥ 60 years old (40%). Ampicillin resistance was observed in 17.1% of cases, displaying β-lactamase production as the principal resistance mechanism. MLST revealed a diverse NTHi population, whereas the encapsulated isolates presented a clonal structure. Conclusion This study describes the prevalence of NTHi isolates circulating in Brazil after two decades of the Hib vaccine immunization program. Continuous universal surveillance is crucial for implementing prompt public health measures to prevent and control invasive Hi disease and monitor changes in antibiotic resistance profiles.
- 15 May 2024
- Published by Springer Nature in International Microbiology
- Vol. 28 (1) , 157-163
Trends in serotype distribution and antimicrobial susceptibility pattern of invasive Haemophilus influenzae isolates from Brazil, 2009–2021
Introduction Invasive Haemophilus influenzae (Hi) disease poses a significant global health challenge. With the relaxation of COVID-19 pandemic measures and declining H. influenzae serotype b (Hib) vaccination coverage, there is concern about a potential increase in Hi cases worldwide. Methodology This study analyzed 1437 invasive Hi isolates in Brazil over 13 years, determining capsular serotypes, antimicrobial susceptibility, and genetic relatedness through multilocus sequence typing. Results The primary source of isolation for these invasive H. influenzae isolates was blood (54.4%), followed by cerebrospinal fluid (37.1%) and lung specimens (8.5%), respectively. Consequently, bacteremia (47%) was the most common clinical presentation, followed by meningitis (39.6%) and pneumonia (13.4%). Non-encapsulated Hi (NTHi) predominated among the isolates (51.4%), along with serotype a (22%) and serotype b (21.5%) among the encapsulated isolates. The majority of the encapsulated isolates were isolated from children under 14 years of age (76.7%), while NTHi isolates were identified in patients older than 15 years, particularly those ≥ 60 years old (40%). Ampicillin resistance was observed in 17.1% of cases, displaying β-lactamase production as the principal resistance mechanism. MLST revealed a diverse NTHi population, whereas the encapsulated isolates presented a clonal structure. Conclusion This study describes the prevalence of NTHi isolates circulating in Brazil after two decades of the Hib vaccine immunization program. Continuous universal surveillance is crucial for implementing prompt public health measures to prevent and control invasive Hi disease and monitor changes in antibiotic resistance profiles.
- Open Access
- 17 February 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (2) , 401
Serotype Distribution and Antimicrobial Susceptibility Pattern of Streptococcus pneumoniae in COVID-19 Pandemic Era in Brazil
Despite the introduction of the pneumococcal vaccine, Streptococcus pneumoniae remains a cause of invasive diseases in Brazil. This study provides the distribution of serotypes and antimicrobial susceptibility patterns for pneumococcal isolates before and during the years of the COVID-19 pandemic in two age groups, S. pneumoniae from the pre-COVID-19 (January 2016 to January 2020) and COVID-19 (February 2020 to May 2022) periods. Antimicrobial resistance was evaluated by disk diffusion and minimum inhibitory concentration. The year 2020 was marked by a 44.6% reduction in isolates received and was followed by an upward trend from 2021 onwards, which became evident in 2022. No differences were observed in serotypes distribution between the studied periods. The COVID-19 period was marked by the high prevalence of serotypes 19A, 3, and 6C in both age groups. Serotypes 19A and 6C were related to non-antimicrobial susceptibility. We observed a reduction in S. pneumoniae, without changes in serotypes distribution and epidemiological capsular switch during the COVID-19 period. We observed elevated resistance rates, mainly to penicillin and ceftriaxone for non-meningitis cases in children under 5 years of age.
- 17 February 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (2) , 401
Open AccessSerotype Distribution and Antimicrobial Susceptibility Pattern of Streptococcus pneumoniae in COVID-19 Pandemic Era in Brazil
Despite the introduction of the pneumococcal vaccine, Streptococcus pneumoniae remains a cause of invasive diseases in Brazil. This study provides the distribution of serotypes and antimicrobial susceptibility patterns for pneumococcal isolates before and during the years of the COVID-19 pandemic in two age groups, S. pneumoniae from the pre-COVID-19 (January 2016 to January 2020) and COVID-19 (February 2020 to May 2022) periods. Antimicrobial resistance was evaluated by disk diffusion and minimum inhibitory concentration. The year 2020 was marked by a 44.6% reduction in isolates received and was followed by an upward trend from 2021 onwards, which became evident in 2022. No differences were observed in serotypes distribution between the studied periods. The COVID-19 period was marked by the high prevalence of serotypes 19A, 3, and 6C in both age groups. Serotypes 19A and 6C were related to non-antimicrobial susceptibility. We observed a reduction in S. pneumoniae, without changes in serotypes distribution and epidemiological capsular switch during the COVID-19 period. We observed elevated resistance rates, mainly to penicillin and ceftriaxone for non-meningitis cases in children under 5 years of age.
- 10 January 2023
- Published by Springer Nature in International Microbiology
- Vol. 26 (3) , 611-618
Genomic characterization of invasive meningococcal X isolates from Brazil, 1992–2022
Introduction Invasive meningococcal disease (IMD) is a major health problem. Given the post-COVID-19 pandemic scenario with the loosening of the non-pharmacological measures to control the virus transmission and considering the observed global reduction of meningococcal vaccination coverage, an increase in IMD cases can be expected. Methodology Using whole-genome sequencing, we characterized six Neisseria meningitidis serogroup X (MenX) isolates recovered from IMD cases in Brazil in the last 30 years. Results The predominance (66.6%, 4/6) of ST2888 presenting fHbp 160, NHBA 129, NadA 21, and PorA 19,15 was found on isolates. Two novel STs, 15458 and 15477, were described. Conclusion This study describes the circulation of MenX lineage ST2888 in Brazil, previously reported only in Europe. Continuous universal surveillance is crucial to implement prompt public health measures aiming to prevent and control non-vaccine preventable serogroup X IMD cases.
- 10 January 2023
- Published by Springer Nature in International Microbiology
- Vol. 26 (3) , 611-618
Genomic characterization of invasive meningococcal X isolates from Brazil, 1992–2022
Introduction Invasive meningococcal disease (IMD) is a major health problem. Given the post-COVID-19 pandemic scenario with the loosening of the non-pharmacological measures to control the virus transmission and considering the observed global reduction of meningococcal vaccination coverage, an increase in IMD cases can be expected. Methodology Using whole-genome sequencing, we characterized six Neisseria meningitidis serogroup X (MenX) isolates recovered from IMD cases in Brazil in the last 30 years. Results The predominance (66.6%, 4/6) of ST2888 presenting fHbp 160, NHBA 129, NadA 21, and PorA 19,15 was found on isolates. Two novel STs, 15458 and 15477, were described. Conclusion This study describes the circulation of MenX lineage ST2888 in Brazil, previously reported only in Europe. Continuous universal surveillance is crucial to implement prompt public health measures aiming to prevent and control non-vaccine preventable serogroup X IMD cases.
- Open Access
- 22 August 2022
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 28 (9) , 1931-1932
Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil
Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil
- 22 August 2022
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 28 (9) , 1931-1932
Open AccessInvasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil
Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil
- Open Access
- 10 February 2022
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 71 (2) , 001484
Emergence of Neisseria meningitidis W South American sublineage strain variant in Brazil: disease and carriage
Introduction. Invasive meningococcal disease is a major health problem, impacting morbidity and mortality worldwide. Exploratory genomics has revealed insights into adaptation, transmissibility and virulence to elucidate endemic, outbreaks or epidemics caused by Neisseria meningitidis serogroup W (MenW) strains. Gap Statement. Limited information on the genomics of Neisseria meningitis serogroup W ST11/cc11 is available from emerging countries, especially in contemporary isolates. Aim. To (i) describe the antigenic diversity and distribution of genetic lineages of N. meningitidis serogroup W circulating in Brazil; (ii) study the carriage prevalence of hypervirulent clones in adolescents students and (iii) analyse the potential risk factors for meningococcal carriage. Methodology. Using whole-genome sequencing, we analysed the genomic diversity of 92 invasive N. meningitidis serogroup W isolates circulating in Brazil from 2016 to 2019. A cross-sectional survey of meningococcal carriage was conducted in 2019, in the city of Florianópolis, Brazil, among a representative sample of 538 students. Results. A predominance (58.5 %, 41/82) of ST11/cc11 presenting PorB2-144, PorA VR1–5, VR2-2, FetA 1–1, and a novel fHbp peptide 1241 was found on invasive N. meningitidis W isolates, on the other hand, a high diversity of clonal complexes was found among carriage isolates. The overall carriage rate was 7.5 % (40/538). A total of 28 of 538 swab samples collected were culture positive for N. meningitidis , including four serogroup/genogroup B isolates (14.8 %;4/27), 1 serogroup/genogroup Y isolate (3.7 %;1/27), 22 (81.5 %; 22/27) non-groupable isolates. No MenW isolate was identified among carriages isolates. Conclusion. This report describes the emergence of the new MenW ST11/cc11 South America sublineage variant, named here, 2016 strain, carrying a novel fHbp peptide 1241, but its emergence, was not associated with an increased MenW carriage prevalence. Continuous surveillance is necessary to ascertain the role of this sublineage diversification and how its emergence can impact transmission.
- 10 February 2022
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 71 (2) , 001484
Open AccessEmergence of Neisseria meningitidis W South American sublineage strain variant in Brazil: disease and carriage
Introduction. Invasive meningococcal disease is a major health problem, impacting morbidity and mortality worldwide. Exploratory genomics has revealed insights into adaptation, transmissibility and virulence to elucidate endemic, outbreaks or epidemics caused by Neisseria meningitidis serogroup W (MenW) strains. Gap Statement. Limited information on the genomics of Neisseria meningitis serogroup W ST11/cc11 is available from emerging countries, especially in contemporary isolates. Aim. To (i) describe the antigenic diversity and distribution of genetic lineages of N. meningitidis serogroup W circulating in Brazil; (ii) study the carriage prevalence of hypervirulent clones in adolescents students and (iii) analyse the potential risk factors for meningococcal carriage. Methodology. Using whole-genome sequencing, we analysed the genomic diversity of 92 invasive N. meningitidis serogroup W isolates circulating in Brazil from 2016 to 2019. A cross-sectional survey of meningococcal carriage was conducted in 2019, in the city of Florianópolis, Brazil, among a representative sample of 538 students. Results. A predominance (58.5 %, 41/82) of ST11/cc11 presenting PorB2-144, PorA VR1–5, VR2-2, FetA 1–1, and a novel fHbp peptide 1241 was found on invasive N. meningitidis W isolates, on the other hand, a high diversity of clonal complexes was found among carriage isolates. The overall carriage rate was 7.5 % (40/538). A total of 28 of 538 swab samples collected were culture positive for N. meningitidis , including four serogroup/genogroup B isolates (14.8 %;4/27), 1 serogroup/genogroup Y isolate (3.7 %;1/27), 22 (81.5 %; 22/27) non-groupable isolates. No MenW isolate was identified among carriages isolates. Conclusion. This report describes the emergence of the new MenW ST11/cc11 South America sublineage variant, named here, 2016 strain, carrying a novel fHbp peptide 1241, but its emergence, was not associated with an increased MenW carriage prevalence. Continuous surveillance is necessary to ascertain the role of this sublineage diversification and how its emergence can impact transmission.